SynthesisJournal of infection and public health2021

Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.

Rizaldy Taslim Pinzon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.